Remarkable ‘clinical studies’ of domestic pharmaceutical companies focusing on future-oriented treatments

Domestic companies have always had desire towards new drugs. However, the problem is it takes so much more time and money to invest in new drugs than generics.

Recently, however, domestic pharmaceutical companies have been liberal with investment on potential fields using the select and concentration strategy. Since the result of a series of clinical study announcements are very positive, thei...